Richard Scheller - Articles and news items

Roche logo

Roche announces phase II clinical results of crenezumab in Alzheimer’s disease

Industry news / 17 July 2014 / Roche

Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease…

Roche logo

Roche’s investigational treatment for asthma met its primary endpoint in a phase II study

Industry news, News / 4 August 2011 / Roche

Lebrikizumab has potential to be the first personalized treatment for asthma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+